Aminoisoquinoline and isoquinoline groups have successfully replaced the more basic P1 benzamidine group of an acylsulfonamide factor VIIa inhibitor. Inhibitory activity was optimized by the identification of additional hydrophobic and hydrophilic P' binding interactions. The molecular details of these interactions were elucidated by X-ray crystallography and molecular modeling. We also show that decreasing the basicity of the P1 group results in improved oral bioavailability in this chemotype.
Keywords: Factor VIIa; Serine protease inhibitors; Structure-based design; TF-FVIIa inhibitor; Tissue factor.
Copyright © 2013 Elsevier Ltd. All rights reserved.